This is a summary of "Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study' by Alex Capano, Richard Weaver and Elisa Burkman, published in Postgraduate Medicine, Vol. 132, 2020, Issue 1.
A prospective, single-arm cohort study for the potential role of cannabinoids as an alternative to opioids was conducted. A prospective cohort study follows a group of similar people (called a cohort) over a period of time, collecting data on their exposure to certain factors. In this case, 131 patients with chronic pain between 30 and 65 years old who have been on opioids for at least a year (the cohort) were exposed to CBD (the factor).
Data were collected at three points: baseline, four weeks, and eight weeks.
Improvement was evaluated using four pain rating indices:
It is important to note that this study has some limitations, such as the need for a control group and a relatively small sample size. Therefore, further research is needed to confirm these findings and explore the long-term effects of CBD use for chronic pain management.
Read full study here.
DISCLAIMER: This content has been partially generated by artificial intelligence and should only be used for informational purposes. This content should not be considered as medical advice; please always consult your doctor to see if alternative plant medicine is suitable for you.
This is a summary of "Illicit Cannabis Usage as a Management Strategy in New Zealand Women with Endometriosis: An Online Survey" by Mike Armour, Justin Sinclair, Geoff Noller, Jane Girling, Maria Larcombe, Mahmoud A. Al-Dabbas, Erika Hollow, Deborah Bush and Neil Johnson, published in Journal of Women's Health. Vol. 30, NO. 10.